Prevalence and boosting of antibodies to Plasmodium falciparum glycosylphosphatidylinositols and evaluation of their association with protection from mild and severe clinical malaria.
about
Immunoregulation in human malaria: the challenge of understanding asymptomatic infectionMalaria: progress, perils, and prospects for eradicationPlasmodium vivax: paroxysm-associated lipids mediate leukocyte aggregation.Determination of the processes driving the acquisition of immunity to malaria using a mathematical transmission modelParasite Carbohydrate Vaccines.Neutralization of malaria glycosylphosphatidylinositol in vitro by serum IgG from malaria-exposed individuals.Cytokine profiling in immigrants with clinical malaria after extended periods of interrupted exposure to Plasmodium falciparum.Asymptomatic infection in individuals from the municipality of Barcelos (Brazilian Amazon) is not associated with the anti-Plasmodium falciparum glycosylphosphatidylinositol antibody response.The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology.Does malaria suffer from lack of memory?Regulating immunity to malaria.Malaria tolerance--for whom the cell tolls?Inflammatory cytokine and humoral responses to Plasmodium falciparum glycosylphosphatidylinositols correlates with malaria immunity and pathogenesis.Targets and Mechanisms Associated with Protection from Severe Plasmodium falciparum Malaria in Kenyan Children.Serum antibody levels to glycosylphosphatidylinositols in specimens derived from matched Malian children with severe or uncomplicated Plasmodium falciparum malaria and healthy controls.Serological markers to measure recent changes in malaria at population level in Cambodia.Lack of an association between antibodies to Plasmodium falciparum glycosylphosphatidylinositols and malaria-associated placental changes in Cameroonian women with preterm and full-term deliveries.Cell biology and immunology of malaria.Chemical biology of glycosylphosphatidylinositol anchors.Antibodies to Plasmodium falciparum rifin proteins are associated with rapid parasite clearance and asymptomatic infectionsIgG antibodies to synthetic GPI are biomarkers of immune-status to both Plasmodium falciparum and Plasmodium vivax malaria in young children.Naturally elicited antibodies to glycosylphosphatidylinositols (GPIs) of Plasmodium falciparum require intact GPI structures for binding and are directed primarily against the conserved glycan moiety.Characterization of a low molecular weight glycolipid antigen from Cryptosporidium parvum.Isolation and purification of glycosylphosphatidylinositols (GPIs) in the schizont stage of Theileria annulata and determination of antibody response to GPI anchors in vaccinated and infected animals.
P2860
Q26775212-FD313F8A-49BA-4615-8C24-5438D50738E1Q27485634-FF7B150A-B0D2-45A3-B37A-C26C00EE631CQ33285318-D7A23819-1463-45F4-90DF-DE120A17E78BQ33312850-50858FF1-7E0D-44FD-B9DC-5E614850F35BQ33785863-DB8CF921-7E36-4CD3-AAFB-3094F84489D0Q34119412-280A59C8-3787-48B2-AD0C-77330089DCA2Q34965621-BD2A53DD-359F-43FF-AFAE-DE2DE8FCD3E1Q34987487-ECAEB5BD-B61F-4D8A-BDAE-C5F33C3A6955Q35180114-30BCFEBE-9CD9-4252-B9FF-1C94381FC473Q35884250-55245696-AFCF-4ED3-8235-CACD80BDFD16Q36378338-3D79B671-69D7-4370-8E8E-959E7A036116Q36511461-31FE93E7-8282-4255-9E24-82DD164D0DCDQ36621046-2DEACAD0-8309-4FE1-919B-31635A90F32DQ36728063-9B9E0FFD-9A19-4A79-B02E-6580CDCAD43AQ37335484-B8D366EA-E9D2-4125-80A3-35FADC79FAABQ37394822-2A2E6FD2-E957-488F-8D9F-362C960BE004Q37521633-509676A6-97A9-4E82-8189-E4FFDEB7B672Q37846879-70913253-94DB-47B2-9E2C-73F1F97F814CQ38054022-7F7528B6-482D-4169-B5EB-C2CF27BBADC3Q38854878-30224DA6-218B-41F1-99AD-E2DEC8B927BDQ41956908-AF0C43E1-722B-4552-A540-F62F99974974Q42135656-F9CFF640-7469-41A3-A969-455D687B859BQ44616334-D4FEDFD0-CC2C-4E71-9082-E16CCCCEA6FEQ49187712-81C53DCC-3683-4241-A5C9-90EF4B9C00D9
P2860
Prevalence and boosting of antibodies to Plasmodium falciparum glycosylphosphatidylinositols and evaluation of their association with protection from mild and severe clinical malaria.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Prevalence and boosting of ant ...... d and severe clinical malaria.
@en
Prevalence and boosting of ant ...... d and severe clinical malaria.
@nl
type
label
Prevalence and boosting of ant ...... d and severe clinical malaria.
@en
Prevalence and boosting of ant ...... d and severe clinical malaria.
@nl
prefLabel
Prevalence and boosting of ant ...... d and severe clinical malaria.
@en
Prevalence and boosting of ant ...... d and severe clinical malaria.
@nl
P2093
P2860
P921
P1476
Prevalence and boosting of ant ...... d and severe clinical malaria.
@en
P2093
D Channe Gowda
Gowdahalli Krishegowda
J Brian de Souza
James Todd
P2860
P304
P356
10.1128/IAI.70.9.5045-5051.2002
P407
P577
2002-09-01T00:00:00Z